The decision to create Symbiosis in 2011 was driven by the need to address specific gaps highlighted in the drug product manufacturing marketplace. Our aim was to accelerate our clients’ drug development timelines by offering rapid access to aseptic fill-finish manufacturing slots and product release services, and this aim is as strong today as it was then.
To make this a reality, a team of experts was assembled that understood what a responsive and agile GMP fill-finish facility needed to be. Since then, our purpose remains resolute and our reputation has grown based on manufacturing expertise and operational flexibility, allowing us to tailor our process solutions to meet the requirements of your project, not the other way round.
As the demand for biological products and more agile clinical manufacturing grows, we are well-placed to assist clients in developing new drug products.
We strive to deliver excellence in all areas of our service and to build mutually beneficial, long-term relationships based on agreed goals and shared objectives.
By definition, symbiotic relationships go beyond the individual agenda. That philosophy led us to call the company ’Symbiosis’.
